You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-SCR-7952
SCR-7952

Chemical Structure : SCR-7952

CAS No.: 2798856-04-7

SCR-7952 (SCR7952)

Catalog No.: PC-23178Not For Human Use, Lab Use Only.

SCR‐7952 is a potent, highly selective methionine adenosyltransferase 2A (MAT2A) inhibitor with IC50 of 18.7 nM, Ki of 14.49 nM, shows MTAP‐null selective antiproliferative activity.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

SCR‐7952 is a potent, highly selective methionine adenosyltransferase 2A (MAT2A) inhibitor with IC50 of 18.7 nM, Ki of 14.49 nM, shows MTAP‐null selective antiproliferative activity.
SCR‐7952 is 3.7‐fold more potent than the previously reported MAT2A inhibitor AG-270 (Cat# PC-72638).
SCR‐7952 dose‐dependently reduces cellular SAM levels with IC50 of 1.9 nM in in HCT116 MTAP−/− cells, three‐fold more potent than AG-270 (IC50 5.8 nM).
SCR‐7952 exhibits a potent antiproliferation effect on HCT116 MTAP−/− cells, with IC50 of 34.4 nM after 6‐day treatment, with low‐to‐moderate antiproliferation activity on MTAP‐WT HCT116 parent cells.
SCR‐7952 inhibits the growth of MTAP‐deleted cell lines H838, MIA PaCa‐2, and A549, with IC50 of 4.3, 19.7, and 123.1 nM, respectively, with little to no effect on MTAP WT cell line WI‐38.
SCR‐7952 dysregulates splicing downstream of MAT2A and triggers DNA damage through its impact on PRMT5 activity.
SCR‐7952 at 3.0 mg/kg presented a stronger tumor growth inhibition than that of AG‐270 at 200 mg/kg (TGI 82.9 vs. 52.0%, p < 0.0001) in HCT116 MTAP −/− subcutaneous xenograft mouse model.

Physicochemical Properties

M.Wt 350.81
Formula C19H15ClN4O
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

7-chloro-5-(2-cyclopropylpyridin-3-yl)-1-methyl-1,5-dihydro-4H-imidazo[4,5-c]quinolin-4-one

References

1. Zhiyong Yu, et al. MedComm (2020). 2024 Sep 20;5(10):e705.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: